Trials / Completed
CompletedNCT03888833
Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation
Risk Factors of Bleeding in Patients Undergoing Peripheral Veno Arterial Extra Corporeal Membrane Oxygenation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 278 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Veno arterial extracorporeal membrane oxygenation (VA ECMO) is used, for cardiogenic shock, refractory cardiac arrest and post cardiotomy cardiac failure. Bleeding is frequent complications during VA ECMO and is associated with increased mortality. The aim of our study was to identify early factors associated with major bleeding in patients supported by VA ECMO
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ECMO | ECMO installation |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2016-12-01
- Completion
- 2018-01-01
- First posted
- 2019-03-25
- Last updated
- 2026-02-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03888833. Inclusion in this directory is not an endorsement.